ID-IRI The study examining dolutegravir/lamivudine in pregnant women living with HIV has started today, and we have sent the study documents to the participant centers via email. If any participants have not received the study documents or if you have any inquiries, please feel free to reach out to Dr. Massimiliano Lanzafame at lanzafame.massimiliano@gmail.com